Sutro Biopharma (NASDAQ:STRO – Get Free Report) was downgraded by research analysts at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued on Friday, MarketBeat.com ...
Tempest Therapeutics (NASDAQ:TPST – Get Free Report) is anticipated to issue its quarterly earnings data before the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback